Rules on cancer treatment financing in Singapore can be improved

Among other things, the Ministry of Health should relook rules on ‘off-label’ drugs.

Waiting for the approval process to be completed could deprive patients of better, and in some cases life-saving, care. PHOTO: PIXABAY
New: Gift this subscriber-only story to your friends and family

Some of the upcoming changes to financing cancer treatments here are good and should cut down needless expenditure.

Higher subsidies, raising the income level so more people qualify for such subsidies and negotiating with drug companies to reduce their prices are all moves in the right direction.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.